Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone suppression test and treatment response.

M J Gitlin, H Gwirtsman, L Fairbanks

    The Journal of Clinical Psychiatry
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Family History and Solar Insolation in Bipolar I Disorder.

    Acta psychiatrica Scandinavica·2026
    Same author

    Early postnatal hepatocyte transplantation in a child with molybdenum cofactor deficiency type B.

    Molecular genetics and metabolism·2025
    Same author

    Radiation therapy facility risk analysis in Brazil with SEVRRA software.

    Journal of radiological protection : official journal of the Society for Radiological Protection·2018
    Same author

    Interactive teaching, medical students, and substance abuse : university and community come together in a new endeavor.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Mechanism of allopurinol induced TPMT inhibition.

    Biochemical pharmacology·2013
    Same author

    Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.

    British journal of cancer·2013

    The dexamethasone suppression test (DST) does not predict antidepressant treatment response in depressed patients, including those with melancholic depression. Neurotransmitter-specific antidepressant efficacy also did not differ between DST suppressors and nonsuppressors.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Clinical Medicine

    Background:

    • The dexamethasone suppression test (DST) is a widely used biomarker in psychiatry.
    • It has been investigated for its potential to predict antidepressant treatment response.
    • Its utility in differentiating between noradrenergic and serotonergic antidepressant efficacy is also explored.

    Purpose of the Study:

    • To evaluate the predictive value of the DST for antidepressant treatment response in a general depressed population.
    • To assess the DST's predictive capability in a subgroup of patients with melancholic depression.
    • To determine if DST status influences response to antidepressants based on neurotransmitter specificity.

    Main Methods:

    • A study involving 173 inpatients and outpatients diagnosed with depression.

    Related Experiment Videos

  • The dexamethasone suppression test (DST) was administered to all participants.
  • Patients received antidepressant treatments stratified by neurotransmitter specificity.

    • Main Results:

    • The DST was not found to be predictive of antidepressant treatment response in the overall cohort of depressed patients.
    • No predictive value of the DST for treatment response was observed in the subgroup of 86 patients with melancholic depression.
    • There were no significant differences in response to neurotransmitter-specific antidepressants between DST suppressors and nonsuppressors.

    Conclusions:

    • The dexamethasone suppression test (DST) lacks predictive utility for antidepressant treatment outcomes in major depression.
    • The DST does not appear to guide the selection of antidepressants based on their neurotransmitter profiles.
    • Further research may be needed to identify reliable biomarkers for predicting antidepressant response.